Funder: National Institutes of Health

Due Dates: June 16, 2025 (New) | July 16, 2025 (Renewal/Resubmission/Revision) | October 16, 2025 (New) | November 16, 2025 (Renewal/Resubmission/Revision) | February 16, 2026 (New) | March 16, 2026 (Renewal/Resubmission/Revision) | and similar dates through November 2027

Funding Amounts: Up to $275,000 direct costs over 2 years; no more than $200,000 in any single year; project period max 2 years.

Summary: Supports translational and mechanistic research on mood and psychosis symptoms during the menopause transition to identify neurobiological, hormonal, and psychosocial treatment targets.

Key Information: Updated March 2025: Carefully review the full NOFO for recent changes and application requirements.